PHAR - KalVista Pharmaceuticals rises after FDA nod for Ekterly
2025-07-07 10:06:53 ET
More on KalVista Pharmaceticals, Pharming
- Pharming Group N.V. 2025 Q1 - Results - Earnings Call Presentation
- Pharming Group N.V. (PHAR) Q1 2025 Earnings Call Transcript
- KalVista: Poised For Rare Disease Transformation
- FDA's Makary sought to reject KalVista’s drug: report
- KalVista said FDA will not meet review date for sebetralstat